IBIO Institute  

About the Institute

Board of Directors

Nancy Joseph-Ridge, M.D.

Nancy Joseph-Ridge, M.D., is president of Takeda Global Research & Development Center, Inc., U.S. In this capacity, Dr. Joseph-Ridge is responsible for overseeing the organization’s development activities. The organization works to develop new product candidates, conduct post-marketing clinical studies and identify and develop innovative lifecycle management approaches for marketed drugs.

Previously, Dr. Joseph-Ridge worked at TAP Pharmaceutical Products Inc., where she was vice president of research and development. Having joined TAP in 2002, she also served as therapeutic area head of Internal Medicine and Rheumatology and department head for publications, medical writing and clinical trial registries.

Before joining TAP, Dr. Joseph-Ridge gained experience in the cardiovascular and arthritis therapeutic areas while working in drug safety and clinical development at Searle, which has since become part of Pfizer.

 

She also brings extensive knowledge of internal medicine, rheumatology and clinical trial work through her clinical and academic roles at the University of Chicago and Rush-Presbyterian-St. Luke’s Medical Center. At the University of Chicago, Dr. Joseph-Ridge served as assistant professor of medicine, director of the Lupus Clinic and medical director of the clinical trials unit. In addition, she worked at Rush as clinical director of the clinical research unit and the Lyme arthritis unit and was assistant professor of medicine and assistant chairman of the department of Medicine at Rush’s medical school.

Dr. Joseph-Ridge earned her medical degree from the University of Illinois at Chicago. She completed her internship and residency in internal medicine at Rush Hospital, where she later became chief resident, and completed her fellowship in Rheumatology at the University of Chicago. Dr. Joseph-Ridge is board certified in both internal medicine and rheumatology.

back